Thrombectomy is the surgical removal of blood clot from a blood vessel. Venous thromboembolism (VTE) is a common lethal disease where blood clots within a vein. These clots can travel to arteries or veins in different parts of the body-brain, heart, kidneys, lungs, and limbs. VTE is considered as the cause of heart attack, stroke; however, it can also damage to the body’s organs or even death. VTE results due to various factors, which include combination of hereditary and acquired risk factors, obesity and post-surgery especially hip, knee, or pelvic surgery. It can be found in smoking population and people who take estrogens or birth control pills. VTE is most common in adults (>60 years) but can occur at any age.
The world thrombectomy devices market is estimated to garner $1,389 million by 2022. This is attributed by the increase in the incidence of acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, and pulmonary embolism due to the sedentary lifestyle, and unhealthy living conditions and habits in the current generation; rise in the geriatric population. The increase in incidence of cardiovascular diseases; growth in demand for minimally-invasive procedures, and demand for better healthcare infrastructure; and increase in competition, has led to technological advancements and innovations. However, lack of trained professionals and awareness, and complicated use of these devices restrict the market growth. In addition, deep vein thrombosis and pulmonary embolism sometimes remain underdiagnosed and can lead to serious health conditions, which can only be avoided by avoiding sedentary lifestyle and creating awareness among all.
The world thrombectomy devices market is segmented into five categories-technology, type, utility, disease, and geography. Based on the type of technology, the market is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, rheolytic thrombectomy devices. Based on type, the market is divided into automated devices and manual devices. Based on utility, the market is classified into reusable devices and disposable devices. The thrombectomy devices market is segmented into three disease categories, which include peripheral diseases, coronary diseases, and neuro diseases. Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players in the thrombectomy devices market. On September 2015, Medtronic acquired Lazarus Effect to strengthen its market of clot removal devices effective during ischemic stroke. Boston Scientific completed the acquisition of interventional business of Bayer AG on May 2014. This made Boston Scientific the leading innovator for peripheral vascular disease in the industry, and expanded their product portfolio and sales force across various geographies.
KEY MARKET BENEFITS:
KEY MARKET SEGMENTS:
The world thrombectomy devices market segmentation is illustrated as follows:
SIMILAR MARKET STUDIES
This report presents a comprehensive overview of the Kirschner Wires market in Europe. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. This report provides a detailed analysis of the market, its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As ...
July 2017 | $2960 | View Details >>
This report presents a comprehensive overview of the Lancets market in Europe. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. This report provides a detailed analysis of the market, its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a ...
July 2017 | $2960 | View Details >>
Fully automatic biochemistry analyzer (FABCA) is a high performance micro-controller based Photometric biochemistry analyzer used to measure various blood biochemical parameters such as blood glucose, urea, protein, and bilirubin etc. that are associated with various disorders such as diabetes, kidney diseases, liver malfunctions and other metabolic derangement’s. The quantization of ...
July 2017 | $3480 | View Details >>
A plethysmograph is an instrument for measuring changes in volume within an organ or whole body (usually resulting from fluctuations in the amount of blood or air it contains). Scope of the Report: This report focuses on the Plethysmograph in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and ...
July 2017 | $4480 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research